It is well established that acute kidney injury (AKI) is a common disease of hospitalized patients associated with significant morbidity and mortality. To date, there are no targeted pharmacotherapies for AKI prevention or treatment, and treatment is entirely supportive, including renal replacement therapy (RRT). Here, we comment on ten barriers for translation of animal data on AKI to the clinical setting. Because the vast majority of studies have been performed in rodent models of AKI, these are a major focus of our comments. and when it happens. The scope of AKI in humans (defined by sCr and urine output) is a late injury event, and our understanding of molecular, cellular, and intrarenal hemodynamic events remains poorly defined. In particular, there is a major knowledge gap concerning the pathophysiology of human AKI-our assumptions are largely based on rodent IRI studies, which can be considered the equivalent of using Galen of Pergamon's manual of anatomy based on dissection of monkeys and pigs to define human anatomy. The National Institutes of Health (NIH) has recently committed resources to studying human AKI by evaluating research biopsies using a variety of "omic" approaches [4]. 4. Some common insults in humans cannot be replicated in small animals Although there are number of recent studies focused on models of myocardial infarction-induced [5] and cardiorenal AKI [6] in rodents (which may lead to a better understanding of these conditions), there is no simple rodent model of contrast-induced AKI, and no model of multifacto-
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Animals can be pretreated or treated at the time that AKI occurs; humans usually cannot

Small animals are inherently more resistant to sepsis
Unlike humans undergoing surgery, rodents undergoing IRI do not require antibiotics to prevent infection. Along the same lines, rodents exposed to bacterial lipopolysaccharides (LPS) to induce a sepsis-like response require much higher doses than humans [7] . Until recently, many rodent models of sepsis did not include supportive care (e.g., fluids, antibiotics) to mimic the human condition. In fact, acute inflammatory stresses cause a characteristic set of genomic responses in humans, but changes in the expression of the murine orthologs of these human genes are close to random in rodents [8] . Thus, the injury and the host response that lead to AKI in these animal models are inherently different than what occurs in humans.
Young animals ≠ elderly humans in terms of disease
susceptibility The expense of maintaining animal colonies for extended periods of time and the desire to complete scientific experiments in an efficient manner have led to the establishment of AKI models that use young animals that undergo a severe and homogenous injury-the predictable nature of the injury results in smaller sample sizes and reduced costs. However, in marked contrast, the humans at greatest risk for AKI are elderly individuals with multiple comorbidities who are often treated with multiple medications, some of which may increase the risk of AKI (such as angiotensin-converting enzyme inhibitors and angiotensin receptor blockers). Furthermore, humans appear to have variable susceptibility to injury. 8. Mice are typically inbred, and humans are not Along the same lines, variability in animal susceptibility to injury has encouraged the use of inbred animals with similar susceptibility to a given insult. Oftentimes, only male animal "subjects" are used because of differences in susceptibility to injury between male and female animals, which further increases the homogeneity of the population studied. We currently have animal models that use young, inbred rodents have been subject to inherent variability due to issues in lack of standardization of models across research groups, inadequate group size, differences in animal housing and chow, as well as seasonal differences [11] . Other challenges to animal studies have included a lack of blinding and power calculations, measures that are standard in human studies. Consequently, even in these models there has been limited reproducibility-so it is again not surprising that results do not translate to humans.
In sum, we have outlined ten important barriers to translating animal studies to humans. Active efforts are ongoing to improve animal models to better simulate human AKI. Ultimately, however, more effort must be placed on understanding human AKI so that the physiological principles that underlie human AKI can be translated backwards to develop better animal models.
